Identificación de infecciones y cambios inmunológicos en pacientes con reacciones adversas al uso de sustancias modelantes en la ciudad de Cali Colombia

dc.contributor.advisorMoreno Castañeda, Jaime Enrique
dc.contributor.advisorLeal Castro, Aura Lucia
dc.contributor.advisorArturo, Jhan
dc.contributor.authorBonilla Moncada, Jennifer Marcela
dc.contributor.researchgroupMicrobiología Instituto Nacional de Saludspa
dc.coverage.countryCali - Colombia
dc.date.accessioned2022-09-06T15:35:44Z
dc.date.available2022-09-06T15:35:44Z
dc.date.issued2022-08-17
dc.descriptionfotografías a color, gráficos, ilustraciones, tablasspa
dc.description.abstractEn la búsqueda de sustancias modelantes (biopolímeros) capaces de proporcionar volumen y generar cambios estéticos sin intervención quirúrgica se han empleado diversos materiales, como sustancias químicas derivadas del petróleo, de origen vegetal y sintético los cuales pueden producir reacciones adversas como procesos infecciosos, inflamatorios y autoinmunes. Objetivo: Identificar las infecciones y cambios inmunológicos en pacientes con reacciones adversas al uso de sustancias modelantes en la ciudad de Cali. Metodología: Es un estudio transversal y descriptivo en el cual se procesaron muestras de tejido para análisis microbiológicos y muestras de sangre total y suero para análisis inmunológicos de 113 pacientes con eventos adversos al uso de biopolímeros en la ciudad de Cali durante 2019-2021. Resultados: Se identificaron aislamientos microbianos en 22 pacientes (19,4 %), 15 (13,2 %) presentaron infecciones mono-microbianas y 7 (6,19 %) pacientes presentaron infecciones polimicrobianas, la frecuencia de los aislamientos identificados fue de Bacillus cereus (n=8, 36,3 %), Mycobacterium fortuitum tipo 2 (n=5, 22,7 %) y Pseudomonas stutzeri (n=3, 13,6 %). Se evidenció un aumento de células T CD4+ en la población de estudio, sin embargo, el promedio del fenotipo celular se encontró por debajo del promedio comparado con el valor de referencia lo que sugiere una tendencia a inmunosupresión con la expresión de autoanticuerpos en 78 (69,0%) pacientes de los cuales SS-B/La (n=32, 60,3%), anti- Ku (n= 22, 28,2 %) y anti -PM-Scl (n=14, 17,9%) anti MPO (n=51, 91,0%) fueron los más frecuentes. La asociación de microorganismos, inflamación y autoinmunidadal uso de sustancias modelantes son hallazgos relevantes para su control. (Texto tomado de la fuente)spa
dc.description.abstractIn the search for modeling substances (biopolymers) capable of providing volume and generating aesthetic changes without surgical intervention, various materials have been used, such as chemical substances derived from petroleum, of vegetable and synthetic origin; which can produce adverse reactions such as infectious, inflammatory and autoimmune processes. Objective: To identify infections and immunological changes in patients with adverse reactions to the use of modeling substances in the city of Cali. Methodology: This is a cross-sectional and descriptive studyin whichtissu e samples were processed for microbiological analysis and whole blood and serum samples for immunological analysis of 113 patients with adverse events to the use of biopolymers in the city of Cali during 2019-2021. Results: Microbial isolates were identified in 22 patients (19.4%), 15 (13.2 %) presented mono-microbial infections and 7 (6.19 %) patients presented polymicrobial infections, the frequency of identified isolates was Bacillus cereus (n=8, 36,3 %), Mycobacterium fortuitum tipo 2 (n=5, 22,7 %) and Pseudomonas stutzeri (n=3, 13,6 %). An increase of CD4+ T cells was evidenced in the study population, however, the average cell phenotype was found below average compared to the reference value suggesting a tendency to immunosuppression with autoantibody expression in 78 (69.0%) patients of which SS-B/La (n=32, 60.3%), anti- Ku (n= 22, 28.2 %) and anti -PM-Scl (n=14, 17.9%) anti MPO (n=51, 91.0%) were the most frequent. The association of microorganisms, inflammation and autoimmunity to the use of modeling substances are relevant findings for their control.eng
dc.description.degreelevelMaestríaspa
dc.description.degreenameMagíster en Ciencias - Microbiologíaspa
dc.description.researchareaInvestigación en Salud públicaspa
dc.format.extent105 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.identifier.instnameUniversidad Nacional de Colombiaspa
dc.identifier.reponameRepositorio Institucional Universidad Nacional de Colombiaspa
dc.identifier.repourlhttps://repositorio.unal.edu.co/spa
dc.identifier.urihttps://repositorio.unal.edu.co/handle/unal/82260
dc.language.isospaspa
dc.publisherInstituto Nacional de Saludspa
dc.publisherInmugen Corporationspa
dc.publisher.branchUniversidad Nacional de Colombia - Sede Bogotáspa
dc.publisher.departmentDepartamento de Geocienciasspa
dc.publisher.facultyFacultad de Cienciasspa
dc.publisher.programBogotá - Ciencias - Maestría en Ciencias - Microbiologíaspa
dc.relation.referencesRiascos A., “Las tragedias diarias de pacientes por uso de biopolímeros en Cali”. Diario el tiempo, Bogotá. 26.07.2018. 29.10.2019. Disponible en: https://www.eltiempo.com/colombia/cali/los-repetidos-dramas-de-pacientes-por-uso- de- biopolimeros-en-cali-248100spa
dc.relation.referencesCoiffman F. Alogenosis iatrogénica. Una nueva enfermedad. Cir Plast Ibero-Latinoamericana. 2008;34(1):1–8.spa
dc.relation.referencesStanford, N., & Montealegre, G. (2013). Alogenosis iatrogénica, hallazgos de una enfermedad reumática. Revista Colombiana de Cirugía Plástica y Reconstructiva, 19(1),28–38spa
dc.relation.referencesRicaurte AI, Forense M, Castaño DA, Castro JA, Paz DA De, Echeverry DA. Alogenosis iatrogénica vs . alogenosis secundaria en Cali , Colombia . 2016;0684.spa
dc.relation.referencesGordillo-Hernández J., Alegre-Tamez E., Torres-Baltazar I., Mendieta-EspinosaM.J., Sastré-Ortiz N.. Abordaje ultidisciplinario de la enfermedad humana por infiltración de sustancias modelantes. Cir. plást. iberolatinoam. [Internet]. 2013 Sep [citado 2021 Nov 18] ; 39( 3 ): 269-277. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0376- 78922013000300009&lng=es. https://dx.doi.org/10.4321/S0376-78922013000300009.spa
dc.relation.referencesCastro Claudia Marcela, Ríos Carlos Alberto, López Carlos Alejandro, Ospina Martha Lucía, Ortiz Yamileth. Efectos adversos de las sustancias modelantes en Cali, Colombia. Biomed. 2021. https://doi.org/10.7705/biomedica.5707.spa
dc.relation.referencesInforme de ponencia para primer debate al proyecto de ley 158 de 2016 cámara. Legis. 07.11.2019. Disponible en: http://www.legisaldia.com/BancoMedios/Archivos/pl-158- 16c-infponencia1debate-regulacioncirugiasesteticas.pdfspa
dc.relation.references"En Cali nació la primera fundación de Colombia que lucha contra los biopolímeros”. Caracol noticias web. Cali. 12.04.2016. 28.09.2019. Disponible en: https://noticias.caracoltv.com/cali/en-cali-nacio-la-primera-fundacion-de-colombia-que- lucha-contra-los-biopolímerosspa
dc.relation.referencesTejero Garcia P. Efectos secundarios de los implantes tisulares: situación actual, protocolo de prevención y tratamiento. (Tesis Doctorado en medicina). Universidad Complutense de Madrid; 2012.spa
dc.relation.referencesSanz-Barriga Helen Amelia, Eróstegui Revilla Carlos Pedro. Alogenosis Iatrogénica, el Gran Peligro de los Biopolímeros. 2010; 13 (1): 31-34. Disponible en: http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1817- 74332010000100010&lng=es.spa
dc.relation.referencesChiang YZ, Pierone G, Al-Niaimi F. Dermal fillers: pathophysiology, prevention and treatment of complications. J Eur Acad Dermatol Venereol. 2017;31(3):405-413. doi:10.1111/jdv.13977spa
dc.relation.referencesDermal Fillers Soft tissue. FDA U.S FOOD & DRUG ADMINISTRATION. 26.10.2021. Disponible en: https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/dermal-fillers-soft-tissue-fillersspa
dc.relation.referencesSánchez-Carpintero I, Candelas D, Ruiz-Rodríguez R. Materiales de relleno: tipos, indicaciones y complicaciones. Actas Dermosifiliogr. 2010;101(5):381–93.spa
dc.relation.referencesFernández-Cossío S, León-Mateos A, Sampedro FG, Oreja MTC. Biocompatibility of agarose gel as a dermal filler: histologic evaluation of subcutaneous implants. Plast Reconstr Surg. 2007;120(5):1161-1169. doi:10.1097/01.prs.0000279475.99934.71spa
dc.relation.referencesGómez DBT, Vargas RB, Ramírez GM, Blancas RBP. Instrumento para evaluar y estadificar el daño producido por la infiltración de sustancias modelantes [Internet]. Medigraphic.com. 2010 [citado el 18 de noviembre de 2020]. Disponible en: https://www.medigraphic.com/pdfs/cplast/cp-2010/cp103b.pdfspa
dc.relation.referencesCastro LFG, Rueda JDA, de Jesús Cano Calle H. Análisis infrarrojo del hialucorp, metacorp y silicona líquida en el marco de la alogenosis iatrogénica. Revista Colombiana de Cirugía Plástica y Reconstructiva [Internet]. 2017 [citado el 18 de noviembre de 2020];23(1). Disponible en: https://www.ciplastica.com/ojs/index.php/rccp/article/view/37spa
dc.relation.referencesDonis AA, Gutiérrez PG, Domínguez NR, Moreno GS, Ávila JR. Filler Materials: A Review [Internet]. Medigraphic.com. [citado el 14 de noviembre de 2021]. Disponible en: https://www.medigraphic.com/pdfs/cosmetica/dcm-2015/dcm151l.pdf.spa
dc.relation.referencesSteven H. Dayan, MD, Benjamin A. Bassichis, MD, Facial Dermal Fillers: Selection of Appropriate Products and Techniques, Aesthetic Surgery Journal, Volume 28, Issue 3, May 2008, Pages 335–347, https://doi.org/10.1016/j.asj.2008.03.004spa
dc.relation.referencesBroder, K. W., & Cohen, S. R. (2006). An overview of permanent and semipermanent fillers. Plastic and reconstructive surgery, 118(3 Suppl), 7S–14S. https://doi.org/10.1097/01.prs.0000234900.26676.0bspa
dc.relation.referencesAlijotas-Reig J, Esteve-Valverde E, Gil-Aliberas N, Garcia-Gimenez V. Autoimmune/inflammatory syndrome induced by adjuvants-ASIA-related to biomaterials:analysis of 45 cases an d comprehensive review of the literature. Immunol Res. 2018;66(1):120-140. doi:10.1007/s12026-017-8980-5spa
dc.relation.referencesGonzález DMG. INFORME DE BIOSEGURIDAD INMUNOLÓGICA DE BIOIMPLANTES: ACIDO HIALURÓNICO [Internet]. Seme.org. [citado el 18 de noviembre de 2021]. Disponible en: https://old.seme.org/docs/Informe-Bioseguridad-Inmunologica- Bioimplantes.pdf?it=docs/Informe-Bioseguridad-Inmunologica-Bioimplantes.pdfspa
dc.relation.referencesTejero P, López Pitalúa JA, Tuffet J, Anido J. Protocolos de práctica clínica en la utilización de materiales de relleno. SEME. 2009; 21:40-47spa
dc.relation.referencesAlimoradi J, Novaa K. (Complications in connection with injection of dermal fillers). Ugeskrift for Laeger. 2019 Mar;181(12). PMID: 30931884.https://doi.org/10.1016/j.jdds.2016.01.001.spa
dc.relation.referencesMurillo J, Torres J, Bofill L, et al. Skin and Wound Infection by Rapidly Growing Mycobacteria: An Unexpected Complication of Liposuction and Liposculpture. Arch Dermatol. 2000;136(11):1347–1352. doi:10.1001/archderm.136.11.1347spa
dc.relation.referencesAnanth-Shenoy, P., Vishwanath, S., Targain, R., Shetty, S., Sunil-Rodrigues, G., Mukhopadhyay, C., & Chawla, K. (2016). Anaerobic infections in surgical wards: a two year study. Iranian journal of microbiology, 8(3), 181–186spa
dc.relation.referencesEsposito, Silvano & Ascione, Tiziana & Pagliano, Pasquale. (2018). Management of bacterial skin and skin structure infections with polymicrobial etiology. Expert Review of Anti- infective Therapy. 17. 10.1080/14787210.2019.1552518.spa
dc.relation.referencesMurray JL, Connell JL, Stacy A, Turner KH, Whiteley M. Mechanisms of synergy in polymicrobial infections. J Microbiol. 2014;52(3):188–99. https://doi.org/10.1007/s12275- 014-4067-3spa
dc.relation.referencesGravante G, Caruso R, Araco A, Cervelli V. Infections after plastic procedures: incidences, etiologies, risk factors, and antibiotic prophylaxis. Aesthetic Plast Surg. 2008;32(2):243-251. doi:10.1007/s00266-007-9068-8spa
dc.relation.referencesFerneini EM, Beauvais D, Aronin SI. An Overview of Infections Associated With Soft Tissue Facial Fillers: Identification, Prevention, and Treatment. J Oral Maxillofac Surg. 2017;75(1):160-166. doi:10.1016/j.joms.2016.09.004spa
dc.relation.referencesGonzalez-Santiago TM, Drage LA. Nontuberculous Mycobacteria: Skin and Soft Tissue Infections. Dermatol Clin. 2015;33(3):563-577. doi:10.1016/j.det.2015.03.017spa
dc.relation.referencesFranco-Paredes C, Marcos LA, Henao-Martínez AF, et al. Cutaneous Mycobacterial Infections. Clin Microbiol Rev. 2018;32(1):e00069-18. Published 2018 Nov 14. doi:10.1128/CMR.00069-18spa
dc.relation.referencesDouglas, Raymond S. M.D., Ph.D.; Cook, Todd M.D.; Shorr, Norman M.D. Lumps and Bumps:, Plastic and Reconstructive Surgery: December 2003 - Volume 112 - Issue 7 - p 1923-1928. https://doi.org/10.1097/01.PRS.0000091423.45859.BDspa
dc.relation.referencesRodriguez JM, Xie YL, Winthrop KL, et al. Mycobacterium chelonae facial infections following injection of dermal filler. Aesthet Surg J. 2013;33(2):265-269. doi:10.1177/1090820X12471944spa
dc.relation.referencesAlcaide F, Esteban J. Infecciones cutáneas y de partes blandas por micobacterias no tuberculosas. Enferm Infecc Microbiol Clin. 2010;28 Suppl 1:46–50.spa
dc.relation.referencesAlijotas-Reig J, Miró-Mur F, Planells-Romeu I, Garcia-Aranda N, Garcia-Gimenez V, Vilardell-Tarrés M. Are bacterial growth and/or chemotaxis increased by filler injections? Implications for the pathogenesis and treatment of filler-related granulomas. Dermatology. 2010;221(4):356–64.spa
dc.relation.referencesAder, Florence & Bernard, Louis. Physiopathologie des infections sur matériel orthopédique. Presse Medicale. 2005 ;34. 533-536.Doi:10.1016/S0755-4982(05)83967-3spa
dc.relation.referencesSchierholz JM, Beuth J. Implant infections: a haven for opportunistic bacteria. J Hosp Infect. 2001;49(2):87-93. doi:10.1053/jhin.2001.1052spa
dc.relation.referencesChristensen L, Breiting V, Janssen M, Vuust J, Hogdall E. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg. 2005;29(1):34-48. doi:10.1007/s00266-004-0113-6spa
dc.relation.referencesGoldan O, Georgiou I, Grabov-Nardini G, et al. Early and late complications after a nonabsorbable hydrogel polymer injection: a series of 14 patients and novel management. Dermatol Surg. 2007;33 Suppl 2:S199-S206. doi:10.1111/j.1524- 4725.2007.33361.xspa
dc.relation.referencesPittet B, Montandon D, Pittet D: Infection in breast implants. Lancet Infect Dis 2005;5:94–106.spa
dc.relation.referencesChristensen L. Host Tissue Interaction, Fate, and Risks of Degradable and Nondegradable Gel Fillers (2009) Dermatologic Surgery Volume: 35, Issue: 2, pp 1612- 1619 DOI: 10.1111/J.1524-4725.2009.01338.Xspa
dc.relation.referencesDecates T, Kadouch J, Velthuis P, Rustemeyer T. Immediate nor delayed type hypersensitivity plays a role in late inflammatory reactions after hyaluronic acid filler injections. Clin Cosmet Investig Dermatol. 2021;14:581–9.spa
dc.relation.referencesLópez C, Manchola JF, Medina-Cárdenas S, Moreno S. Reacción granulomatosa de tipo cuerpo extraño secundaria a biomateriales y su respuesta inmunológica: Revisión sistemática de la literatura. Salut Sci Spirit [Internet]. 2016 [citado el 18 de noviembre de 2021];2(1). Disponible en: https://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/1385.spa
dc.relation.referencesKindt TJ, Goldsby RA, Osborne BA, Martínez RP. Inmunología de Kuby [Internet]. McGraw-Hill; 2007. Available from: https://books.google.com.co/books?id=2xpqMwAACAAJspa
dc.relation.referencesMicheels P. Human anti-hyaluronic acid antibodies: is it possible?. Dermatol Surg. 2001;27(2):185-191. doi:10.1046/j.1524-4725.2001.00248.xBspa
dc.relation.referencesBigatà X, Ribera M, Bielsa I, Ferrándiz C. Adverse granulomatous reaction after cosmetic dermal silicone injection. Dermatol Surg. 2001;27(2):198-200. doi:10.1046/j.1524- 4725.2001.00020.xspa
dc.relation.referencesLowe NJ, Maxwell CA, Lowe P, Duick MG, Shah K. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol. 2001;45(6):930-933. doi:10.1067/mjd.2001.117381.spa
dc.relation.referencesJones P, Mempin M, Hu H, et al. The Functional Influence of Breast Implant Outer Shell Morphology on Bacterial Attachment and Growth. Plast Reconstr Surg. 2018;142(4):837-849. doi:10.1097/PRS.0000000000004801spa
dc.relation.referencesLee JM, Kim YJ. Foreign body granulomas after the use of dermal fillers: pathophysiology, clinical appearance, histologic features, and treatment. Arch Plast Surg. 2015;42(2):232-239. doi:10.5999/aps.2015.42.2.232spa
dc.relation.referencesBhojani-Lynch, Tahera MRCOphth, CertLRS, MBCAM, DipCS Late-Onset Inflammatory Response to Hyaluronic Acid Dermal Fillers, Plastic and Reconstructive Surgery - Global Open: December 2017 - Volume 5 - Issue 12 - p e1532 doi: 10.1097/GOX.0000000000001532spa
dc.relation.referencesErcilla González G. (2010). Informe de bioseguridad inmunológica de implantes: ácido hialurónico. SEME; 24:7-13spa
dc.relation.referencesYel L, Chen W, Gupta S. Cellular immunodeficiency and autoimmunity in long-term mineral oil administration. Ann Allergy Asthma Immunol. 2004;92(1):88-91. doi:10.1016/S1081-1206(10)61716-4spa
dc.relation.referencesAlijotas-Reig J, Fernández-Figueras MT, Puig L. Late-onset inflammatory adverse reactions related to soft tissue filler injections. Clin Rev Allergy Immunol. 2013;45(1):97-108. doi:10.1007/s12016-012-8348-5spa
dc.relation.referencesLedon JA, Savas JA, Yang S, Franca K, Camacho I, Nouri K. Inflammatory nodules following soft tissue filler use: a review of causative agents, pathology and treatment options. Am J Clin Dermatol. 2013;14(5):401-411. doi:10.1007/s40257-013-0043-7spa
dc.relation.referencesMontealegre G, Uribe R, Martínez-Ceballos MA, Rojas-Villarraga A. ASIA syndrome symptoms induced by gluteal biopolymer injections: Case-series and narrative review. Toxicol Rep. 2021;8:303-314. Published 2021 Jan 27. doi:10.1016/j.toxrep.2021.01.011spa
dc.relation.referencesTamayo Carbón AM, Castellanos Prada AR, Aveiro-Róbalo TR. Alogenosis Iatrogénica Y Enfermedades Reumáticas. Rev cuba reumatol. 2018;20(2):18.spa
dc.relation.referencesAmeratunga R, Gillis D, Gold M, Linneberg A, Elwood JM. Evidence Refuting the Existence of Autoimmune/Autoinflammatory Syndrome Induced by Adjuvants (ASIA). J Allergy Clin Immunol Pract. 2017;5(6):1551-1555.e1. doi:10.1016/j.jaip.2017.06.033spa
dc.relation.referencesWatad A, Quaresma M, Brown S, et al. Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome) - An update. Lupus. 2017;26(7):675-681. doi:10.1177/0961203316686406spa
dc.relation.referencesFerrer-Cosme B, Téllez-Martínez D, Batista-Duharte A. inflamatorio inducido por adyuvantes. ¿Una nueva entidad clínica? [Internet]. Medigraphic.com. [citado el 18 de noviembre de 2021]. Disponible en: https://www.medigraphic.com/pdfs/imss/im- 2017/im173n.spa
dc.relation.referencesNunes E Silva D, Gründler C, Spengler MDGMT, et al. Autoimmune Syndrome Induced by Adjuvants (ASIA) after Silicone Breast Augmentation Surgery. Plast Reconstr Surg Glob Open. 2017;5(9):e1487. Published 2017 Sep 25. doi:10.1097/GOX.0000000000001487spa
dc.relation.referencesCappellano G, Ploner C, Lobenwein S, et al. Immunophenotypic characterization of human T cells after in vitro exposure to different silicone breast implant surfaces. PLoS One. 2018;13(2):e0192108. Published 2018 Feb 8. doi:10.1371/journal.pone.0192108spa
dc.relation.referencesIsraeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Adjuvants and autoimmunity. Lupus. 2009;18(13):1217-1225. doi:10.1177/0961203309345724.spa
dc.relation.referencesFernández de Vega F, Moreno J, González J, Palacios J. Procedimientos en microbiología Clínica Recomendaciones de la Sociedad Española de enfermedades Infecciosas y Microbiología Clínica. 2005. ISBN: 84-609-7032-9spa
dc.relation.referencesDingle TC, Butler-Wu SM. Maldi-tof mass spectrometry for microorganism identification. Clin Lab Med. 2013;33(3):589-609. doi:10.1016/j.cll.2013.03.001spa
dc.relation.referencesAbu-Zhayia, E.R., Khoury-Haddad, H., Guttmann-Raviv, N. et al. A role of human RNase P subunits, Rpp29 and Rpp21, in homology directed-repair of double-strand breaks. Sci Rep 7, 1002 (2017). https://doi.org/10.1038/s41598-017-01185-6spa
dc.relation.referencesWorld Health Organization & Centers for Disease Control and Prevention (U.S.). (2011). Laboratory methods for the diagnosis of meningitis caused by neisseria meningitidis, streptococcus pneumoniae, and haemophilus influenzae : WHO manual, 2nd ed. World Health Organization. https://apps.who.int/iris/handle/10665/70765spa
dc.relation.referencesChurch DL, Cerutti L, Gürtler A, Griener T, Zelazny A, Emler S. Performance and Application of 16S rRNA Gene Cycle Sequencing for Routine Identification of Bacteria in the Clinical Microbiology Laboratory. Clin Microbiol Rev. 2020;33(4):e00053-19. Published 2020 Sep 9. doi:10.1128/CMR.00053-19spa
dc.relation.referencesJo J-H, Kennedy EA, Kong HH. Research techniques made simple: Bacterial 16S ribosomal RNA gene sequencing in cutaneous research. J Invest Dermatol. 2016;136(3):e23–7.spa
dc.relation.referencesNadkarni MA, Martin FE, Jacques NA, Hunter N. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology (Reading). 2002;148(Pt 1):257-266. doi:10.1099/00221287-148-1-257spa
dc.relation.referencesEdwards KJ, Logan JMJ, Langham S, Swift C, Gharbia SE. Utility of real-time amplification of selected 16S rRNA gene sequences as a tool for detection and identification of microbial signatures directly from clinical samples. J Med Microbiol. 2012;61(Pt 5):645-652. doi:10.1099/jmm.0.041764-0spa
dc.relation.referencesNadkarni MA, Martin FE, Jacques NA, Hunter N. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology (Reading). 2002;148(Pt 1):257-266. doi:10.1099/00221287-148-1-257spa
dc.relation.referencesWu YD, Li W, Wei Y, Gao HH, Shang SQ, Du LZ. Rapid and Sensitive Identification of Bacterial Infection and Bacteria Gram Types in Pleural Fluid of Children. Glob Pediatr Health. 2015; 2:2333794X15569302. Published 2015 Jan 30. doi:10.1177/2333794X15569302spa
dc.relation.referencesDEVALLOIS A, GOH K.S, RASTOGI N. Rapid identification of mycobacteria to species level by PCR-restriction fragment length polymorphism analysis of the hsp65 gene and proposition of an algorithm to differentiate 34 mycobacterial species. J Clin Microbiol 1997; 35:2969-2973spa
dc.relation.referencesHäfner B, Haag H, Geiss HK, Nolte O. Different molecular methods for the identification of rarely isolated non-tuberculous mycobacteria and description of new hsp65 restriction fragment length polymorphism patterns. Mol Cell Probes. 2004;18(1):59-65. doi: 10.1016/j.mcp.2003.09.003spa
dc.relation.referencesTelenti A, Marchesi F, Balz M, Bally F, Böttger EC, Bodmer T. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol. 1993;31(2):175-178. doi:10.1128/jcm.31.2.175- 178.1993spa
dc.relation.referencesZhang HJ, Pan Z, Wei JC, et al. Optimization of Pulsed-field Gel Electrophoresis Procedure for Bacillus cereus. Biomed Environ Sci. 2016;29(3):233-237. doi:10.3967/bes2016.030spa
dc.relation.referencesNeoh HM, Tan XE, Sapri HF, Tan TL. Pulsed-field gel electrophoresis (PFGE): A review of the "gold standard" for bacteria typing and current alternatives. Infect Genet Evol. 2019;74:103935. doi: 10.1016/j.meegid.2019.103935spa
dc.relation.referencesKaminska PS, Fiedoruk K, Jankowska D, et al. One-day pulsed-field gel electrophoresis protocol for rapid determination of emetic Bacillus cereus isolates. Electrophoresis. 2015;36(7-8):1051-1054. doi:10.1002/elps.201400552spa
dc.relation.referencesTenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33(9):2233-2239. doi:10.1128/jcm.33.9.2233- 2239.1995spa
dc.relation.referencesKwong JC, McCallum N, Sintchenko V, Howden BP. Whole genome sequencing in clinical and public health microbiology. Pathology. 2015;47(3):199-210. doi:10.1097/PAT.0000000000000235spa
dc.relation.referencesBianco A, Capozzi L, Monno MR, et al. Characterization of Bacillus cereus Group Isolates From Human Bacteremia by Whole-Genome Sequencing. Front Microbiol. 2021;11:599524. Published 2021 Jan 12. doi:10.3389/fmicb.2020.599524spa
dc.relation.referencesCossarizza A, Chang HD, Radbruch A, et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). Eur J Immunol. 2019;49(10):1457-1973. doi:10.1002/eji.201970107spa
dc.relation.referencesMendez-Rayo, Tatiana, Ochoa-Zárate, Laura, Posso-Osorio, Iván, Ortiz, Eliana, Naranjo-Escobar, Juan, & Tdbón, Gabriel J.. (2018). Interpretación de los autoanticuerpos en enfermedades reumatológicas. Revista Colombiana de Reumatología, 25(2), 112-125. https://doi.org/10.1016/j.rcreu.2018.02.004spa
dc.relation.referencesKryštůfková O, Hulejová H, Mann HF, et al. Serum levels of B-cell activating factorof the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis. Arthritis Res Ther. 2018;20(1):158. Published 2018 Jul 27.doi:10.1186/s13075-018-1650-8spa
dc.relation.referencesReyes L., León F., Rozas F., Gonzalez P., Naves R., BAFF: Una citoquina reguladora de linfocitos B implicada en autoinmunidad y cáncer linfoide. Rev. méd. Chile (online). 2006, vol.134, n.9, pp.1175-1184. ISSN 0034-9887. http://dx.doi.org/10.4067/S0034-98872006000900014.spa
dc.relation.referencesSmulski CR, Eibel H. BAFF and BAFF-Receptor in B Cell Selection and Survival. Front Immunol. 2018;9:2285. Published 2018 Oct 8.doi:10.3389/fimmu.2018.02285spa
dc.relation.referencesPisetsky D. S. (2017). Antinuclear antibody testing - misunderstood or misbegotten?. Nature reviews. Rheumatology, 13(8), 495–502. https://doi.org/10.1038/nrrheum.2017.74spa
dc.relation.referencesGeetha D, Jefferson JA. ANCA-Associated Vasculitis: Core Curriculum 2020. Am J Kidney Dis. 2020;75(1):124-137. doi:10.1053/j.ajkd.2019.04.031spa
dc.relation.referencesThieblemont N,Wright HL, Edwards SW,Witko-Sarsat V. Human neutrophils in auto- immunity. Semin Immunol. 2016;28(2):159–73.spa
dc.relation.referencesNakazawa D, Masuda S, Tomaru U, Ishizu A. Pathogenesis and therapeutic interventions for ANCA-associated vasculitis [published correction appears in Nat Rev Rheumatol. 2019 Jan 17]. Nat Rev Rheumatol. 2019;15(2):91-101. doi:10.1038/s41584-018-0145-yspa
dc.relation.referencesMendez-Rayo, Tatiana, Ochoa-Zárate, Laura, Posso-Osorio, Iván, Ortiz, Eliana, Naranjo-Escobar, Juan, & Tdbón, Gabriel J.. (2018). Interpretación de los autoanticuerpos en enfermedades reumatológicas. Revista Colombiana de Reumatología, 25(2), 112-125. https://doi.org/10.1016/j.rcreu.2018.02.004spa
dc.relation.referencesGonzález Rodríguez, C., Aparicio Hernández, M. & Alarcón Torres, I. (2021). Actualización y manejo clínico de los anticuerpos anti-ácido desoxirribonucleico. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 2(3), 322- 331. https://doi.org/10.1515/almed-2020-0067spa
dc.relation.referencesGómez-Puerta, J. A., Burlingame, R. W., & Cervera, R.(2006). Anti-chromatin (anti- nucleosome) antibodies. Lupus, 15(7), 408–411. https://doi.org/10.1191/0961203306lu2325oaspa
dc.relation.referencesCozzani, E., Drosera, M., Gasparini, G., & Parodi, A. (2014). Serology of Lupus Erythematosus: Correlation between Immunopathological Features and Clinical Aspects. Autoimmune diseases, 2014, 321359. https://doi.org/10.1155/2014/321359spa
dc.relation.referencesMahler M. (2011). Sm peptides in differentiation of autoimmune diseases. Advances in clinical chemistry, 54, 109–128. https://doi.org/10.1016/b978-0-12-387025- 4.00005-4spa
dc.relation.referencesOhzeki, J. I., Otake, K., & Masumoto, H. (2020). Human artificial chromosome: Chromatin assembly mechanisms and CENP-B. Experimental cellresearch, 389(2), 111900. https://doi.org/10.1016/j.yexcr.2020.111900spa
dc.relation.referencesKoenig, M., Dieudé, M., & Senécal, J. L. (2008). Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies. Autoimmunity reviews, 7(8), 588–593. https://doi.org/10.1016/j.autrev.2008.06.010spa
dc.relation.referencesChatterjee, S., & Prayson, R. A. (2020). Concurrent anti-PM-Scl antibody-associated systemic sclerosis and inclusion body myositis - report of two cases and review of the literature. Seminars in arthritis and rheumatism, 50(3), 498–502. https://doi.org/10.1016/j.semarthrit.2019.11.008spa
dc.relation.referencesGhirardello, A., Zampieri, S., Iaccarino, L., Tarricone, E., Bendo, R., Gambari, P. F., & Doria, A. (2005). Anti-Mi-2 antibodies. Autoimmunity, 38(1), 79–83. https://doi.org/10.1080/08916930400022681spa
dc.relation.referencesBelizna, C., Henrion, D., Beucher, A., Lavigne, C., Ghaali, A., & Lévesque, H. (2010). Anti-Ku antibodies: Clinical, genetic and diagnostic insights. Autoimmunity reviews, 9(10), 691–694. https://doi.org/10.1016/j.autrev.2010.05.020spa
dc.relation.referencesFranceschini, F., & Cavazzana, I. (2005). Anti-Ro/SSA and La/SSB antibodies. Autoimmunity, 38(1), 55–63. https://doi.org/10.1080/08916930400022954spa
dc.relation.referencesKattah NH, Kattah MG, Utz PJ. The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases. Immunol Rev. 2010;233(1):126- 145. doi:10.1111/j.0105-2896.2009.00863.xspa
dc.relation.referencesZampieri S, Ghirardello A, Iaccarino L, Tarricone E, Gambari PF, Doria A. Anti-Jo-1 antibodies. Autoimmunity. 2005;38(1):73-78. doi:10.1080/08916930400022640spa
dc.relation.referencesRodríguez EC, Díaz-Guevara P, Moreno J, Bautista A, Montaño L, Realpe ME, Della Gaspera A, Wiesner M. Laboratory surveillance of Salmonella enterica from human clinical cases in Colombia 2005-2011. Enferm Infecc Microbiol Clin. 2017 Aug- Sep;35(7):417-425. English, Spanish. doi: 10.1016/j.eimc.2016.02.023. Epub 2016 Mar 30. PMID: 27038678.spa
dc.relation.referencesComans-Bitter WM, de Groot R, van den Beemd R, Neijens HJ, Hop WC, Groeneveld K, et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr 1997; 130: 388-93.spa
dc.relation.referencesChristensen L, Breiting V, Bjarnsholt T, Eickhardt S, Høgdall E, Janssen M, et al. Bacterial infection as a likely cause of adverse reactions to polyacrylamide hydrogel fillers in cosmetic surgery. Clin Infect Dis. 2013;56(10):1438–44.spa
dc.relation.referencesMeneghetti KL, do Canto Canabarro M, Otton LM, Dos Santos Hain T, Geimba MP, Corção G. Bacterial contamination of human skin allografts and antimicrobial resistance: a skin bank problem. BMC Microbiol. 2018;18(1):121. Published 2018 Sep 24. doi:10.1186/s12866-018-1261-1spa
dc.relation.referencesDominguez-Zambrano A., Haddad-Tame J.L., Torres-Baltazar I., Jiménez- Muñoz G., Satré-Ortíz N., Espinosa-Maceda S.. Enfermedad por modelantes: problemática actual en México y presentación de casos. Cir. plást. iberolatinoam. [Internet]. 2013 Dic [citado 2021 Nov 18] ; 39( 4 ): 399-405. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S037678922013000400010 &lng=es. https://dx.doi.org/10.4321/S0376-spa
dc.relation.referencesBusscher HJ, van der Mei HC, Subbiahdoss G, et al. Biomaterial-associated infection: locating the finish line in the race for the surface. Sci Transl Med. 2012;4(153):153rv10. doi:10.1126/scitranslmed.3004528spa
dc.relation.referencesYel L, Chen W, Gupta S. Cellular immunodeficiency and autoimmunity in long-term mineral oil administration. Ann Allergy Asthma Immunol. 2004;92(1):88-91. doi:10.1016/S1081-1206(10)61716-4spa
dc.relation.referencesDubouix A, Bonnet E, Alvarez M, et al. Bacillus cereus infections in Traumatology- Orthopaedics Department: retrospective investigation and improvement of healthcare practices. J Infect. 2005;50(1):22-30. doi:10.1016/j.jinf.2004.05.012spa
dc.relation.referencesWang, Y., Leng, V., Patel, V. et al. Injections through skin colonized with Staphylococcus aureus biofilm introduce contamination despite standard antimicrobial preparation procedures. Sci Rep 7, 45070 (2017). https://doi.org/10.1038/srep45070spa
dc.relation.referencesEhling-Schulz M, Lereclus D, Koehler TM. The Bacillus cereus Group: Bacillus Species with Pathogenic Potential. Microbiol Spectr. 2019;7(3):10.1128/microbiolspec.GPP3-0032-2018. doi:10.1128/microbiolspec.GPP3-0032-2018spa
dc.relation.referencesThomas MS,Wigneshweraraj S. Regulation of virulence gene expression. Virulence. 2014;5(8):832-834. doi:10.1080/21505594.2014.995573spa
dc.relation.referencesMarculescu CE, Berbari EF, Cockerill FR 3rd, Osmon DR. Unusual aerobic and anaerobic bacteria associated with prosthetic joint infections. Clin Orthop Relat Res. 2006;451:55-63. doi:10.1097/01.blo.0000229317.43631.81spa
dc.relation.referencesBrown MM, Horswill AR. Staphylococcus epidermidis-Skin friend or foe?. PLoS Pathog. 2020;16(11):e1009026. Published 2020 Nov 12. doi:10.1371/journal.ppat.1009026spa
dc.relation.referencesMarculescu CE, Berbari EF, Cockerill FR 3rd, Osmon DR. Unusual aerobic and anaerobic bacteria associated with prosthetic joint infections. Clin Orthop Relat Res. 2006;451:55-63. doi:10.1097/01.blo.0000229317.43631.81spa
dc.relation.referencesMånsson E, Hellmark B, Sundqvist M, Söderquist B. Sequence types of Staphylococcus epidermidis associated with prosthetic joint infections are not present in the laminar airflow during prosthetic joint surgery. APMIS. 2015;123(7):589-595. doi:10.1111/apm.12392spa
dc.relation.referencesOtto M. Staphylococcus epidermidis--the 'accidental' pathogen. Nat Rev Microbiol. 2009;7(8):555-567. doi:10.1038/nrmicro2182spa
dc.relation.referencesHeldt Manica LA, Cohen PR. Staphylococcus lugdunensis infections of the skin and soft tissue: A case series and review. Dermatol Ther (Heidelb). 2017;7(4):555–62.spa
dc.relation.referencesTevell S, Hellmark B, Nilsdotter-Augustinsson Å, Söderquist B. Staphylococcus capitis isolated from prosthetic joint infections. Eur J Clin Microbiol Infect Dis. 2017;36(1):115-122. doi:10.1007/s10096-016-2777-7spa
dc.relation.referencesLeonel C, Sena IFG, Silva WN, et al. Staphylococcus epidermidis role in the skin microenvironment. J Cell Mol Med. 2019;23(9):5949-5955. doi:10.1111/jcmm.14415spa
dc.relation.referencesChoi M, Cheon JS, Choi WY, Son KM, Ki JS, Kim Y. An outbreak of Pseudomonas stutzeri bacterial isolation caused by sterile dressing products. J Wound Manag Res. 2017;13(1):24–7.spa
dc.relation.referencesOspina Fabio Enrique, Betancur Juan Felipe, Suso Juan Pablo, Muñoz-Buitro Evelyn, Cañas Carlos Alberto, Tobón Gabriel J.. Papel de la citocina BAFF en las enfermedades autoinmunes: rol fisiopatológico y estrategias terapéuticas. Rev.Colomb.Reumatol; 23( 3 ): 177-194. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0121- 81232016000300006&lng=en. https://doi.org/10.1016/j.rcreu.2016.06.003spa
dc.relation.referencesAlijotas-Reig J, Fernández-Figueras MT, Puig L. Inflammatory, immune-mediated adverse reactions related to soft tissue dermal fillers. Semin Arthritis Rheum. 2013;43(2):241-258. doi:10.1016/j.semarthrit.2013.02.001spa
dc.relation.referencesAlijotas-Reig J, Fernández-Figueras MT, Puig L. Inflammatory, immune-mediated adverse reactions related to soft tissue dermal fillers. Semin Arthritis Rheum. 2013;43(2):241-258. doi:10.1016/j.semarthrit.2013.02.001spa
dc.relation.referencesMaijers MC, de Blok CJ, Niessen FB, et al. Women with silicone breast implants and unexplained systemic symptoms: a descriptive cohort study. Neth J Med. 2013;71(10):534- 540.spa
dc.relation.referencesPsianou K, Panagoulias I, Papanastasiou AD, et al. Clinical and immunological parameters of Sjögren's syndrome. Autoimmun Rev. 2018;17(10):1053-1064. doi:10.1016/j.autrev.2018.05.005spa
dc.relation.referencesBelizna C, Henrion D, Beucher A, Lavigne C, Ghaali A, Lévesque H. Anti-Ku antibodies: Clinical, genetic and diagnostic insights. Autoimmun Rev. 2010;9(10):691-694. doi:10.1016/j.autrev.2010.05.020spa
dc.relation.referencesChatterjee S, Prayson RA. Concurrent anti-PM-Scl antibody-associated systemic sclerosis and inclusion body myositis - report of two cases and review of the literature. Semin Arthritis Rheum. 2020;50(3):498-502. doi:10.1016/j.semarthrit.2019.11.008spa
dc.relation.referencesChatterjee S, Prayson RA. Concurrent anti-PM-Scl antibody-associated systemic sclerosis and inclusion body myositis - report of two cases and review of the literature. Semin Arthritis Rheum. 2020;50(3):498-502. doi:10.1016/j.semarthrit.2019.11.008spa
dc.relation.referencesSchmidt J. Current Classification and Management of Inflammatory Myopathies. J Neuromuscul Dis. 2018;5(2):109-129. doi:10.3233/JND-180308spa
dc.relation.referencesPisetsky DS, Lipsky PE. New insights into the role of antinuclear antibodies in systemic lupus erythematosus. Nat Rev Rheumatol. 2020;16(10):565-579. doi:10.1038/s41584-020-0480-7spa
dc.relation.referencesSapkota B, Al Khalili Y. Mixed connective tissue disease. En: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.spa
dc.relation.referencesStrzepa A, Pritchard KA, Dittel BN. Myeloperoxidase: A new player in autoimmunity. Cell Immunol. 2017;317:1-8. doi:10.1016/j.cellimm.2017.05.002spa
dc.relation.referencesRipalda A, Loja A, Víctor L, Herrera P, Freites P. Consecuencias Clínicas Del Uso De Biopolímeros Como Prácticas De Auto-Atención En El Proceso De Trasformación Corporal En Personas Transexuales. // Clinical Consequences of the Use of Biopolymers As Self- Attention Practices in the Process of Body Transfor. Facsalud-Unemi [Internet]. 2018;2(2):46–52. Available from: http://ojs.unemi.edu.ec/index.php/facsalud- unemi/article/view/723/0.spa
dc.relation.referencesInternational Society of Aesthetic Plastic Surgery. International Survey on Aesthetic/Cosmetic., Procedures Performed in 2015. Fecha de consulta: 28.09.2019. Disponible en: https://www.isaps.org/wp-content/uploads/2018/10/2017-Global-Survey- Press-Release-Demand-for-Cosmetic-Surgery-Procedures-Around-The-World-Continues- To-Skyrocket_2_RW.pdfspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.licenseAtribución-NoComercial-SinDerivadas 4.0 Internacionalspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/spa
dc.subject.armarcBeauty, personaleng
dc.subject.lembCosméticaspa
dc.subject.lembBeauty cultureeng
dc.subject.lembBelleza personalspa
dc.subject.proposalBiopolímerosspa
dc.subject.proposalInfeccionesspa
dc.subject.proposalAutoinmunidadspa
dc.subject.proposalSubpoblaciones celularesspa
dc.subject.proposalBAFFspa
dc.titleIdentificación de infecciones y cambios inmunológicos en pacientes con reacciones adversas al uso de sustancias modelantes en la ciudad de Cali Colombiaspa
dc.title.translatedIdentification of infections and immunological changes in patients with adverse with adverse reactions to the use of modeling substances in the city of cali city of Cali, Colombiaeng
dc.typeTrabajo de grado - Maestríaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdccspa
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.type.driverinfo:eu-repo/semantics/masterThesisspa
dc.type.redcolhttp://purl.org/redcol/resource_type/TMspa
dc.type.versioninfo:eu-repo/semantics/acceptedVersionspa
dcterms.audience.professionaldevelopmentEstudiantesspa
dcterms.audience.professionaldevelopmentInvestigadoresspa
dcterms.audience.professionaldevelopmentMedios de comunicaciónspa
dcterms.audience.professionaldevelopmentPadres y familiasspa
dcterms.audience.professionaldevelopmentPúblico generalspa
oaire.accessrightshttp://purl.org/coar/access_right/c_abf2spa
oaire.awardtitleIDENTIFICACIÓN DE INFECCIONES Y CAMBIOS INMUNOLÓGICOS EN PACIENTES CON REACCIONES ADVERSAS AL USO DE SUSTANCIAS MODELANTES EN LA CIUDAD DE CALI COLOMBIAspa
oaire.fundernameColciencias- Código registro MinCiencias: 58178spa

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
1072668744.2022.pdf
Tamaño:
1.96 MB
Formato:
Adobe Portable Document Format
Descripción:
Tesis de Maestría en Microbiología

Bloque de licencias

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
4.57 KB
Formato:
Item-specific license agreed upon to submission
Descripción: